Skip to content
Mendelspod Podcast cover art

All episodes

Mendelspod Podcast, 582 episodes. Page 2 of 6.

#
Title
101

What Next for LDTs? A Conversation with Sarah Overton of Velsera

102

AI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com

103

We've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude's

104

Aaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer Research

105

Toward Disease Sub-typing with Ben Busby, DNAnexus

106

Synthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John Cumbers

107

Beyond the Parts List: Chris Mason and Simon Fredriksson on Mapping the Immune System in Space and Cancer with Cell Surface Proteomics

108

DNA Is Still Where It's At: Christian Henry, CEO of PacBio, on Watershed Year in 2024

109

A New Sequencing Technology Has Entered the World: Keith Robison Reviews AGBT and New Tech in our Annual Sequencing--er, Multi-Omics Show

110

Unlocking the Future of Forensic Genetics with Mirna Ghemrawi

111

Public Science in Peril: Hank Greely of Stanford on Funding, Fishing, and the Fight for Knowledge

112

Breaking the ‘Undruggable’ Barrier with AI and Synthetic Biology: Eswar Iyer, CEO of Aikium

113

"They're not cutting a branch. They're cutting the whole tree." Laura Hercher Defends DEI in Genomic Research and Medicine

114

Early Detection for Lung Cancer with Susan Tousi, DELFI Diagnostics

115

Big RNA with Brendan Frey of Deep Genomics

116

Genome Informatics in the Age of AI With Ben Busby, DNAnexus

117

AI & the Future of Genetic Testing: Ezra Cohen, CMO of Tempus

118

PredxBio and the Promise of Spatially Intelligent Biology

119

Surprise: Our Most Popular Show of 2024 Was on Genomic AI

120

New Startup Launches Epigenetic Screening: Mohamad Takwa, CEO, Epigenica

121

AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina

122

Renowned GI Oncologist Discusses MRD Testing and the Future of Cancer Detection

123

Precision Medicine Then and Now: We Talk with the Retiring President of the Personalized Medicine Coalition, Ed Abrahams

124

MicroRNA: A New Era in Biomarker Discovery with Tim Williams and Paola Ulivi

125

Somatic Genomics: A Revolution in Biology with Jacob Rubens

126

Exploring the Future of Single Cell Technology with Mauro Muraro, CEO, Single Cell Discoveries

127

Grail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik Bajaj

128

Singular Genomics Introduces a Dual-Purpose Platform Capable of Both NGS and Spatial Multiomics: Drew Spaventa, CEO & Founder

129

The Evolving Future of Genetic Counseling with Ellen Matloff, CEO, MyGeneCounsel

130

As Sequencing Continues to Scale, Volta Labs Improves Sample Prep: Udayan Umapathi, CEO

131

What’s Next for Large-Scale Proteomics? With Chris Whelan, Janssen

132

Will this At-Home Blood Collection Device Transform Medicine? Ben Casavant, Tasso

133

Geneticist Kevin Mitchell Attempts to Naturalize Free Will in New Book

134

ctDNA Testing Could Lead to New Ways of Staging Cancer Patients, Says Ben Weinberg, MedStar Georgetown

135

14th Season Opener: Michael Levin on ‘The New Biology’

136

The Success of ctDNA Testing in Colorectal Cancer: Adham Jurdi, Natera

137

Henrik Zetterberg on the Current Excitement Around Alzheimer’s Research

138

The Reboot of Consumer Genomics? with Kian Sadeghi, Nucleus Genomics

139

From Geospatial to Biospatial: Avi Veidman of Nucleai

140

New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio

141

Diagnostic Trends in 2024 with Mara Aspinall, Illumina Ventures

142

The Actionable Epigenome with Bret Barnes, Illumina

143

Not All Prenatal Screens Are the Same: Jennifer Hoskovec, Billion to One

144

Harvard's Marc Lipsitch on the New White House Policy Regulating Risky Pathogen Research

145

Liquid Biopsy Goes Beyond Cancer: Diana Abdueva and Maggie Louie, Aqtual

146

Cell Therapy Will Transform Medicine as We Know It, Says Jason Bock, CTMC

147

Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data

148

Single Cell Spatial Proteomics with Filip Karlsson, Pixelgen

149

The Precision Medicine Optimist: Damon Hostin, Illumina

150

An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer

151

How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh

152

The Pre-Symptomatic Space with Patrick Short, Sano Genetics

153

Systemwide Implementation of Precision Medicine at UCHealth with David Kao

154

Is this New Tech a Game Changer for Spatial Biology?

155

Synthetic Biology in 2024 with John Cumbers

156

Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom

157

The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo

158

Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy

159

Precision Medicine for Dogs: Christina Lopes, OneHealth

160

Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome

161

Christian Henry of PacBio on Long Reads at Scale, Next Moves

162

Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing

163

Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox

164

What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF

165

Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post

166

Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics

167

Todd Druley of Mission Bio on Single Cell Multi-Omics

168

Kevin Davies on Gene Therapy in 2023

169

History and State of Proteomics 2023 with John Yates

170

New Philosophy of Biology Series on PBS: A Preview with Host Robert Lawrence Kuhn

171

Mapping the Meta Proteome: John Shon, CTO, Serimmune

172

Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech

173

Chris Hall and Rich Chen of Personalis on Next Gen MRD Testing

174

State of Sequencing 2023: Shawn Baker and Keith Robison

175

Newborn Sequencing 2023 Part II: What Evidence Is Enough?

176

Lincoln Nadauld on the State of Precision Medicine in 2023

177

Nothing Is "Undruggable:" Alex Federation, CEO, Talus Bio

178

Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific

179

This Is Very Cool: Treating Cancer with Sound

180

The Future of Clinical Proteomics with Jenny Van Eyk and Daniel Hornburg

181

Elinor Karlsson on Darwin’s Ark

182

Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech

183

Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences

184

13th Season Opener: Mike Snyder on Microsampling and Multi-Omic Profiling

185

Gene Patent Decision at 10 Years, State of Genetic Testing with Ellen Matloff, My Gene Counsel

186

Proteomics Bigger than Genomics, It’s Just Taking Time, Says Jeff Hawkins, CEO, Quantum-SI

187

Biden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023

188

Proteomics Today Where Genomics Was in the 80s: Margaret Donovan and Asim Siddiqui of Seer on Landmark Study

189

Is This New Platform an Answer to the Reproducibility Crisis? with Guy Rohkin

190

Elegen Pioneers Long DNA Subindustry with CEO Matt Hill

191

Nevermind the $200 Genome, Element CEO Molly He Says Core Chemistry Capable of Much More

192

3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics

193

New Spatial Company Maps Cell Surface Proteome without Imaging

194

John Greally on His Latest Review of Epigenomics

195

President of ASHG on Eugenics Apology, Diversity Initiative

196

23andMe Launches New Personalized Healthcare Initiative with Amy Sturm

197

Converting Digital to Biological: John Gill, Telesis Bio

198

50% Not Tested: Precision Oncology with Jerome Madison, Invitae

199

Paul Freemont on Synthetic Biology in the UK

200

The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics